+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sarepta Therapeutics - logo

Sarepta Therapeutics is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of rare neuromuscular diseases. The company offers EXONDYS 51, a disease-modifying therapy for the treatment of duchenne muscular dystrophy (DMD). It also develops SRP-4045 and SRP-4053, which are exon skipping clinical product candidates for the treatment of DMD. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.

Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • October 2020
  • 211 Pages
  • Global
From
From
From
From
OTC Drugs, Medical Devices and Diagnostics: Global Markets - Product Thumbnail Image

OTC Drugs, Medical Devices and Diagnostics: Global Markets

  • Report
  • June 2020
  • 317 Pages
  • Global
From
From
Global Market for Regenerative Medicine (RM), 2019 - Product Thumbnail Image

Global Market for Regenerative Medicine (RM), 2019

  • Report
  • July 2019
  • 391 Pages
  • Global
From
From
Mucopolysaccharidosis Treatment Global Market Report 2024 - Product Thumbnail Image

Mucopolysaccharidosis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Loading Indicator